Key result
Telemedicine cuts all-cause mortality ~35% vs usual care in HFrEF patients.
Why the study?
Telemedicine has improved adherence to heart failure treatment, but has not yet been tailored specifically to address heart failure with reduced ejection fraction.
Does telemedicine reduce mortality and hospitalization in outpatients with heart failure with reduced ejection fraction?
Meta-Analysis (n=9,737)
Does telemedicine reduce mortality and hospitalization in outpatients with heart failure with reduced ejection fraction?
Effect estimate: OR 0.65 (95% CI 0.54 - 0.78)
p-value: p=<0.00001
Telemedicine significantly reduces all-cause mortality, cardiovascular mortality, and heart failure-related hospitalizations in patients with HFrEF.
Supports telemedicine integration into HFrEF outpatient care; confirms mortality benefit across pooled trials.
<ns4:p>Abstract* Background Telemedicine has improved adherence to heart failure (HF) treatment, however it has not yet been tailored specifically to address HF with reduced ejection fraction (HFrEF). Our objective is to undertake a comprehensive systematic review and meta-analysis of existing research studies that focus on telemedicine in HFrEF. Methods We conducted an extensive literature review encompassing trials which included outpatients with HFrEF who underwent telemedicine compared with usual care. We exclude any studies without ejection fraction data. Three bibliographic databases from PubMed, ScienceDirect, and Cochrane Library were utilized in our search from January 1999 to May 2023. The endpoints of interest included all-cause mortality, cardiovascular-related mortality, all-cause hospitalization, and HF-related hospitalization. The Cochrane risk-of-bias (RoB) and the risk of bias in non-randomized studies – of interventions (ROBINS-I) were used for non-randomized or observational studies. To quantitatively analyze the collective findings, a pooled odds ratio (OR) was computed for each outcome. Results Out of the initial pool of 4,947 articles, we narrowed down our analysis to 27 studies, Results showed that telemedicine significantly reduced all-cause mortality (OR: 0.65; 95% CI 0.54 – 0.78; p<0.00001), cardiovascular-related mortality (OR 0.68, 95% CI 0.58 – 0.80, p < 0.00001), and HF-related hospitalization based on number of events (OR 0.77, 95% CI 0.64 – 0.94, p = 0.009) as well as number of patients (OR 0.78, 95% CI 0.69 – 0.87, p < 0.0001). Conclusion Telemedicine was shown significantly beneficial in decreasing mortality and hospitalization in HFrEF patients. Future research should focus on standardizing effective telemedicine practices due to the existing variability in methods and clinical situation of the patients. PROSPERO: CRD42023471222 registerd on October 21, 2023</ns4:p>
No takes yet. Share an insight, caveat, or question.
William et al. (2024) conducted a meta-analysis in Heart failure with reduced ejection fraction (HFrEF) (n=9,737). Telemedicine vs. Usual care was evaluated on All-cause mortality (OR 0.65, 95% CI 0.54 - 0.78, p=<0.00001). Telemedicine significantly reduced all-cause mortality (OR 0.65) compared to usual care in patients with heart failure with reduced ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: